BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4976852)

  • 21. [The dynamics of serum-free amino acid concentration in newborn infants with hemolytic disease].
    Egorova AI; Aksenova NM
    Vopr Okhr Materin Det; 1972 Jan; 17(1):87-8. PubMed ID: 4629897
    [No Abstract]   [Full Text] [Related]  

  • 22. [Late anemia in hemolytic disease of the newborn].
    Molaro GL; Vazzoler G
    Minerva Pediatr; 1966 Nov; 18(35):2072-7. PubMed ID: 4969530
    [No Abstract]   [Full Text] [Related]  

  • 23. [Aspects of ABO blood group incompatibility in the pre- and postnatal periods].
    Novachev D; Markov L
    Akush Ginekol (Sofiia); 1980; 19(4):322-8. PubMed ID: 6774626
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serum complement in hemolytic disease of the newborn].
    Gravina E; Gravina-Sanvitale G
    Minerva Pediatr; 1971 Feb; 23(5):199-203. PubMed ID: 4995757
    [No Abstract]   [Full Text] [Related]  

  • 25. [Errors and disagreements in the determination of factor RhO (D)].
    Ducos J; Ruffié J; Marty Y
    Rev Fr Transfus; 1969; 12(1):Suppl:81-91. PubMed ID: 4987787
    [No Abstract]   [Full Text] [Related]  

  • 26. Estimation of the number of females at risk of isoimmunization to the Rho (D) antigen in a sample of the population attended at the Instituto Mexicano del Seguro Social.
    Zavala C; Velázquez-Ferrari MA; Navarrete C; Rosales-Corona J; Lisker R
    Arch Invest Med (Mex); 1983; 14(2):199-206. PubMed ID: 6416200
    [No Abstract]   [Full Text] [Related]  

  • 27. [Red blood cell levels of acetylcholinesterase in newborn infants with hyperbilirubinemia and asphyxia].
    Mydlil V; Tomásová H; Cápová E; Cerná M
    Cesk Pediatr; 1973 Oct; 28(10):548-50. PubMed ID: 4203257
    [No Abstract]   [Full Text] [Related]  

  • 28. SEROLOGICAL ASPECT OF HEMOLYTIC DISEASE OF NEWBORN.
    ISLAMI ZS
    Va Med Mon (1918); 1963 Oct; 90():530. PubMed ID: 14069389
    [No Abstract]   [Full Text] [Related]  

  • 29. Twin pregnancy and erythroblastosis.
    Beischer NA; Pepperell RJ; Barrie JU
    Obstet Gynecol; 1969 Jul; 34(1):22-9. PubMed ID: 4978195
    [No Abstract]   [Full Text] [Related]  

  • 30. [Objective evaluation of the efficacy of dietary management of hypercholesterolemia by a gas chromatographic study of plasma and erythrocyte fatty acids].
    Ricci G; Angelico F; Amodeo P; Arca M; Cantafora A
    Clin Ter; 1980 Nov; 95(4):353-61. PubMed ID: 7214848
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fractionation of human erythrocytes according to their sedimentation behaviour caused by gravity. II. Application for the differential diagnosis of erythroblastosis caused by incompatibility in the abo blood group system (author's transl)].
    Schulz D; Rothenhöfer C; Faul A
    Monatsschr Kinderheilkd (1902); 1978 Oct; 126(10):611-5. PubMed ID: 568212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serological conflict].
    Marianowski L
    Pieleg Polozna; 1982; (1-2):4-5, 15. PubMed ID: 6808531
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of leukocytic isosensitization in pregnancy on the condition of the newborn infant].
    Kuznechikova VV; Vasil'eva ZF; Poliakova GP
    Vopr Okhr Materin Det; 1971 Jan; 16(1):40-5. PubMed ID: 4995798
    [No Abstract]   [Full Text] [Related]  

  • 34. [Development and present status of immunoprophylaxis of Rh-sensitization].
    Radzuweit H
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1181-5. PubMed ID: 4994101
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of Rh immunization in primigravidae and risk of immunization in multiparae.
    Lundsgaard A
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):450-1. PubMed ID: 5003524
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of Rh sensitization by means of anti D application].
    Schneider J
    Bibl Haematol; 1969; 32():113-23. PubMed ID: 4980798
    [No Abstract]   [Full Text] [Related]  

  • 37. Fetal blood group determination in amniotic cells.
    Vázquez-Escobosa C; Pérez-Medina R; Ramos-Damián ME; Gómez-Estrada H
    Arch Invest Med (Mex); 1982; 13(2):101-4 passim. PubMed ID: 6808946
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed anemia in erythroblastosis fetalis.
    Strand C; Polesky HF
    Minn Med; 1972 May; 55(5):439-41. PubMed ID: 4624082
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immune-prevention of fetal erythroblastosis].
    Schubert W
    Z Arztl Fortbild (Jena); 1971 Jun; 65(11):540-5. PubMed ID: 4998879
    [No Abstract]   [Full Text] [Related]  

  • 40. Antenatal serologic assessment of severity of hemolytic disease due to anti-Rh.
    Frankowska K
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):613-9. PubMed ID: 5006484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.